326 filings
Page 3 of 17
424B5
INDP
Indaptus Therapeutics Inc
10 Aug 20
Prospectus supplement for primary offering
8:43am
8-K
INDP
Indaptus Therapeutics Inc
10 Aug 20
Intec Pharma Announces Pricing of $4.9 Million Registered Direct Offering
8:40am
10-Q
2020 Q2
INDP
Indaptus Therapeutics Inc
Quarterly report
5 Aug 20
9:19am
8-K
INDP
Indaptus Therapeutics Inc
5 Aug 20
Intec Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:08am
4
INDP
Indaptus Therapeutics Inc
17 Jul 20
Intec Pharma / Roger Pomerantz ownership change
4:39pm
4
INDP
Indaptus Therapeutics Inc
17 Jul 20
Intec Pharma / Jeffrey A Meckler ownership change
4:38pm
4
INDP
Indaptus Therapeutics Inc
17 Jul 20
Intec Pharma / ANTHONY J MADDALUNA ownership change
4:34pm
4
INDP
Indaptus Therapeutics Inc
17 Jul 20
Intec Pharma / Hila Karah ownership change
4:33pm
4
Hayes William B
17 Jul 20
Intec Pharma / William B Hayes ownership change
4:33pm
4
Kozarich John W
17 Jul 20
Intec Pharma / JOHN W KOZARICH ownership change
4:30pm
8-K
INDP
Indaptus Therapeutics Inc
17 Jul 20
Departure of Directors or Certain Officers
4:30pm
EFFECT
INDP
Indaptus Therapeutics Inc
17 Jun 20
Notice of effectiveness
12:15am
424B3
INDP
Indaptus Therapeutics Inc
16 Jun 20
Prospectus supplement
4:53pm
CORRESP
INDP
Indaptus Therapeutics Inc
16 Jun 20
Correspondence with SEC
12:00am
UPLOAD
INDP
Indaptus Therapeutics Inc
15 Jun 20
Letter from SEC
12:00am
DEF 14A
INDP
Indaptus Therapeutics Inc
Definitive proxy
8 Jun 20
5:21pm
8-K
INDP
Indaptus Therapeutics Inc
8 Jun 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:00pm
S-1
INDP
Indaptus Therapeutics Inc
5 Jun 20
IPO registration
4:30pm
PRE 14A
INDP
Indaptus Therapeutics Inc
Preliminary proxy
26 May 20
5:15pm
D
INDP
Indaptus Therapeutics Inc
19 May 20
$5M in options / securities to be acquired, sold $5M, 4 investors
4:30pm